Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus
Public ClinicalTrials.gov record NCT01061606. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Pilot Phase II Study of Temsirolimus in Patients With Recurrent Mixed Mesodermal and Mullerian Tumors (Carcinosarcoma) of the Uterus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This phase II trial is studying how well temsirolimus works in treating patients with recurrent or persistent cancer of the uterus. Temsirolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Study identification
- NCT ID
- NCT01061606
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 8 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2009
- Primary completion
- Mar 31, 2012
- Completion
- Sep 30, 2012
- Last update posted
- Nov 8, 2016
2010 – 2012
United States locations
- U.S. sites
- 20
- U.S. states
- 6
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Tower Cancer Research Foundation | Beverly Hills | California | 90211-1850 | — |
| City of Hope | Duarte | California | 91010 | — |
| Los Angeles County-USC Medical Center | Los Angeles | California | 90033 | — |
| City of Hope Medical Group Inc | Pasadena | California | 91105 | — |
| University of California at Davis Cancer Center | Sacramento | California | 95817 | — |
| University of Connecticut | Farmington | Connecticut | 06030 | — |
| Yale University | New Haven | Connecticut | 06520 | — |
| Morristown Memorial Hospital | Morristown | New Jersey | 07962 | — |
| The Valley Hospital-Luckow Pavilion | Paramus | New Jersey | 07652 | — |
| Women's Cancer Care Associates LLC | Albany | New York | 12208 | — |
| Beth Israel Medical Center | New York | New York | 10003 | — |
| New York University Langone Medical Center | New York | New York | 10016 | — |
| Saint Luke's Roosevelt Hospital Center - Roosevelt Division | New York | New York | 10019 | — |
| Presbyterian-Weill Medical College | New York | New York | 10021 | — |
| Mount Sinai School of Medicine | New York | New York | 10029 | — |
| Children's Hospital of New York Presbyterian | New York | New York | 10032 | — |
| Columbia University College of Physicians and Surgeons | New York | New York | 10032 | — |
| Montefiore Medical Center - Moses Campus | The Bronx | New York | 10467-2490 | — |
| Penn State Hershey Children's Hospital | Hershey | Pennsylvania | 17033 | — |
| University of Texas Health Science Center at San Antonio | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01061606, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 8, 2016 · Synced Sep 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01061606 live on ClinicalTrials.gov.